Galapagos Share Price (GLPG.AM)

Galapagos is listed on the Euronext Amsterdam trading with ticker code GLPG.AM. It has a market capitalisation of €1.70b, with approximately 65.90m shares in issue. Over the last year, Galapagos share price has been traded in a range of 15.36, hitting a high of 40.26, and a low of 24.90. It is classified as being part of the Biotechnology subsector.

Galapagos is a Belgian biotechnology company headquartered in Mechelen. Specialising in drug discovery and development, it focuses on creating innovative therapies for various diseases, including inflammation and fibrosis. Leveraging its proprietary target discovery platform, Galapagos aims to address unmet medical needs and improve patient outcomes. The company's pipeline includes promising candidates in clinical development, demonstrating its commitment to advancing medical science. With a strong emphasis on research and collaboration, Galapagos collaborates with leading pharmaceutical companies and academic institutions to accelerate the development of novel treatments.